Technical Analysis for AGE - AgeX Therapeutics, Inc.

Grade Last Price % Change Price Change
B 16.90 -24.27% -5.42
AGE closed down 24.27 percent on Monday, March 18, 2024, on 28 percent of normal volume.
Earnings due: Mar 29
*** please verify all earnings dates ***
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Jack-in-the-Box Bullish Bullish Swing Setup 0.00%
Wide Range Bar Range Expansion 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Inside Day Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Crossed Above 200 DMA Bullish -24.27%
Golden Cross Bullish -24.27%

   Recent Intraday Alerts

Alert Time
Possible Inside Day about 8 hours ago
60 Minute Opening Range Breakdown about 11 hours ago
Down 5% about 13 hours ago
Down 3% about 13 hours ago
Down 2 % about 13 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AgeX Therapeutics, Inc. Description

AgeX is a biotechnology company focused on the development of novel therapeutics for age-related degenerative disease. AgeX’s mission is to apply the proprietary technology platform related to telomerase-mediated cell immortality and regenerative biology to address a broad range of diseases of aging. The current preclinical development efforts include two cell-based therapies derived from telomerase-positive pluripotent stem cells and two product candidates derived from the company’s proprietary induced Tissue Regeneration (iTR™) technology. AGEX-BAT1 and AGEX-VASC1 are cell-based approaches in the preclinical stage of development comprised of young regenerative cells modified using AgeX’s UniverCyte™ technology facilitating immune tolerance, formulated in HyStem® matrix, designed to correct metabolic imbalances in aging and to restore vascular support in ischemic tissues respectively. AGEX-iTR1547 is a drug-based formulation in preclinical development intended to restore regenerative potential in a wide array of aged tissues afflicted with degenerative disease using the company’s proprietary iTR technology. Renelon™ is a first-generation iTR product designed to promote scarless tissue repair which AgeX plans to initially develop as a topically-administered device for commercial development through a 510(k) application. In addition to the product candidates in early development, AgeX, through its LifeMap subsidiary, currently markets genomic interpretation algorithms. AgeX also markets Cytiva® comprised of PSC-derived heart muscle cells used in screening drugs for efficacy and safety.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Biology Disease Clinical Development Stem Cell Cell Biology Product Design Algorithms Degenerative Disease Cloning Tissue Engineering Developmental Biology Telomerase

Is AGE a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 22.32
52 Week Low 0.3104
Average Volume 82,871
200-Day Moving Average 0.77
50-Day Moving Average 1.16
20-Day Moving Average 2.31
10-Day Moving Average 4.25
Average True Range 2.01
RSI (14) 78.77
ADX 28.92
+DI 72.55
-DI 0.23
Chandelier Exit (Long, 3 ATRs) 16.29
Chandelier Exit (Short, 3 ATRs) 6.37
Upper Bollinger Bands 13.97
Lower Bollinger Band -9.34
Percent B (%b) 1.13
BandWidth 1007.77
MACD Line 2.68
MACD Signal Line 0.82
MACD Histogram 1.8582
Fundamentals Value
Market Cap 1.49 Billion
Num Shares 88 Million
EPS -0.38
Price-to-Earnings (P/E) Ratio -44.48
Price-to-Sales 362.10
Price-to-Book 12.96
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.16
Resistance 3 (R3) 27.72 24.85 25.45
Resistance 2 (R2) 24.85 22.24 24.58 24.88
Resistance 1 (R1) 20.88 20.63 19.45 20.32 24.31
Pivot Point 18.01 18.01 17.30 17.74 18.01
Support 1 (S1) 14.04 15.40 12.61 13.48 9.49
Support 2 (S2) 11.17 13.79 10.90 8.92
Support 3 (S3) 7.20 11.17 8.35
Support 4 (S4) 6.64